CAPR - CIK 0001133869
CAPRICOR THERAPEUTICS, INC. (CAPR) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | -100.0% |
| FY 2024 | $22.27M | -11.5% |
| FY 2023 | $25.18M | +886.8% |
| FY 2022 | $2.55M | +941.8% |
| FY 2021 | $244.90K | -21.1% |
| FY 2020 | $310.25K | -69.1% |
| FY 2019 | $1.01M | -39.9% |
| FY 2018 | $1.67M | -37.3% |
| FY 2017 |
CAPRICOR THERAPEUTICS, INC. (CAPR) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CAPRICOR THERAPEUTICS, INC.'s revenue declined from $1.35M to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.67M |
| -33.3% |
| FY 2016 | $4.00M | -27.5% |
| FY 2015 | $5.52M | +15.3% |
| FY 2014 | $4.79M | +851.2% |
| FY 2013 | $503.23K | +157.4% |
| FY 2012 | $195.50K | -85.6% |
| FY 2011 | $1.35M | - |